‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
JAMA Oncology Author Interviews
Chronic Toxic Effects Following Adjuvant Anti–PD-1 Therapy for High-Risk Resected Melanoma
30
00:00:00
/ 00:17:39
30